Neurotransmitters have been pathologically altered in PD condition with a decrease of the striatal DA and GABA levels and an increase of the striatal Glu and Ach levels (Barone, 2010; Jamwal and Kumar, 2019). The gene discussed is FGFR3; the disease is Parkinson disease.